| Antiplatelet Therapy |
Valid Value (%) |
NV/NA (%) |
|
| Valid Value |
69718 ( 90.4) |
0 ( 0.0) |
69718 ( 90.4) |
| NV/NA |
7401 ( 9.6) |
0 ( 0.0) |
7401 ( 9.6) |
|
77119 (100.0) |
0 ( 0.0) |
77119 (100.0) |
Table 5.2.15.1 : Antiplatelet Therapy (by Type of Diabetes)
| CMH Chi-Square |
p.value |
df |
| 50356.0535 |
0 |
1 |
|
Barplot 5.2.15.1 - Antiplatelet Therapy (by Type of Diabetes)
| Antiplatelet Therapy |
Type 1 (%) |
Type 2 (%) |
|
| Yes |
2004 ( 20.8) |
27640 ( 46.0) |
29644 ( 42.5) |
| No |
7647 ( 79.2) |
32427 ( 54.0) |
40074 ( 57.5) |
|
9651 ( 13.8) |
60067 ( 86.2) |
69718 (100.0) |
Table 5.2.15.2 : Antiplatelet Therapy (by Type of Diabetes)
| CMH Chi-Square |
p.value |
df |
| 2168.1536 |
0 |
1 |
|
Barplot 5.2.15.2 - Antiplatelet Therapy (by Type of Diabetes)
|
Barplot 5.2.15.2a - Antiplatelet Therapy (by Data Source, Type of Diabetes = Type 1)
|
Barplot 5.2.15.2b - Antiplatelet Therapy (by Data Source, Type of Diabetes = Type 2)
| s |
O |
E |
N |
CR |
AR |
C.I. (95%) |
[O-E]/E % |
C.I. [O-E]/E (95%) |
| 18 |
194 |
79 |
236 |
82.2 |
51.0 |
( 47.5; 54.5) |
145.6 |
( 135.1;156.1) |
| 01 |
6 |
3 |
27 |
22.2 |
41.5 |
( 17.8; 65.3) |
100.0 |
(-113.5;313.5) |
| 12 |
957 |
736 |
3294 |
29.1 |
27.0 |
( 25.8; 28.2) |
30.0 |
( 24.8; 35.3) |
| 19 |
189 |
226 |
1155 |
16.4 |
17.4 |
( 15.2; 19.5) |
-16.4 |
( -27.3; -5.5) |
| 04 |
499 |
678 |
3768 |
13.2 |
15.3 |
( 14.0; 16.5) |
-26.4 |
( -33.3;-19.5) |
| 10 |
141 |
229 |
958 |
14.7 |
12.8 |
( 10.7; 14.9) |
-38.4 |
( -47.2;-29.7) |
| 08 |
18 |
42 |
183 |
9.8 |
8.9 |
( 4.0; 13.8) |
-57.1 |
( -78.7;-35.6) |
| T |
2004 |
|
9621 |
20.8 |
|
|
|
|
Table 5.2.15.3 - Standardized Estimates:
5.2.15 Percentage of adults w antiplatelet therapy
(Type of Diabetes = Type 1 )
|
Barplots (Adjusted Rates): 5.2.15.1 5.2.15 Percentage of adults w antiplatelet therapy - Type of Diabetes = Type 1
|
Forest plots: 5.2.15.1 5.2.15 Percentage of adults w antiplatelet therapy - Type of Diabetes = Type 1
| s |
O |
E |
N |
CR |
AR |
C.I. (95%) |
[O-E]/E % |
C.I. [O-E]/E (95%) |
| 18 |
5119 |
3309 |
7416 |
69.0 |
71.2 |
( 70.0; 72.3) |
54.7 |
( 52.1; 57.3) |
| 12 |
4942 |
3386 |
7173 |
68.9 |
67.2 |
( 66.1; 68.3) |
46.0 |
( 43.6; 48.3) |
| 19 |
1180 |
1057 |
2451 |
48.1 |
51.4 |
( 49.3; 53.4) |
11.6 |
( 6.9; 16.4) |
| 01 |
189 |
192 |
443 |
42.7 |
45.3 |
( 40.5; 50.1) |
-1.6 |
(-12.6; 9.5) |
| 10 |
3444 |
3599 |
7884 |
43.7 |
44.0 |
( 43.0; 45.1) |
-4.3 |
( -6.7; -1.9) |
| 08 |
477 |
531 |
1140 |
41.8 |
41.3 |
( 38.5; 44.1) |
-10.2 |
(-16.2; -4.2) |
| 04 |
12199 |
15050 |
32330 |
37.7 |
37.3 |
( 36.8; 37.8) |
-18.9 |
(-20.1;-17.8) |
| 09 |
90 |
519 |
1230 |
7.3 |
8.0 |
( 5.0; 10.9) |
-82.7 |
(-89.7;-75.7) |
| T |
27640 |
|
60067 |
46.0 |
|
|
|
|
Table 5.2.15.4 - Standardized Estimates:
5.2.15 Percentage of adults w antiplatelet therapy
(Type of Diabetes = Type 2 )
|
Barplots (Adjusted Rates): 5.2.15.2 5.2.15 Percentage of adults w antiplatelet therapy - Type of Diabetes = Type 2
|
Forest plots: 5.2.15.2 5.2.15 Percentage of adults w antiplatelet therapy - Type of Diabetes = Type 2
